FindTrial
Sign In

A Study to evaluate the disease activity in Non-segmental vitiligo.

The presence of NLRP1 inflammosome immuno-staining and its correlation with disease activity in Non-segmental vitiligo. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061435
Enrollment
30
Registered
2024-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Dr Ashwini Ashokan
Lead Sponsor
Indian Association of Dermatologist Venereologists and Leprologists
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting to the dermatology OPD with generalized/non-segmental vitiligo .

Exclusion criteria

Exclusion criteria: 1) Segmental vitiligo 2) Non-segmental vitiligo patients who received any topical or systemic therapy in past 3 months duration. 3) 4) Associated autoimmune diseases 5) Pregnant or lactating mothers

Design outcomes

Primary

MeasureTime frame
The presence of NLRP1 immunostaining in Non-segmental vitiligo and correlate the NLRP1 immuno-staining intensity with clinical activity in Non-segmental vitiligo using VETF scoring system Timepoint: 18 months—

Secondary

MeasureTime frame
To correlate the histopathological features of Non-segmental vitiligo using Vitiligo Histopathological scoring system proposed by Yadav et al with clinical activity / stability us-ing VETF scoring system.Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Ashwini Ashokan

Amrita Institute of Medical Sciences

soumyavivek@gmail.com09447130395

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026